Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone

NCT01924286 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Immune Reconstitution Inflammatory Syndrome
HIV
Tuberculosis

Interventions

DRUG: Prednisone
DRUG: Placebo

Sponsor

University of Cape Town

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]